🇺🇸 FDA
Pipeline program

Delgocitinib cream, Cream Vehicle

LP0133-2393

Phase 2 small_molecule active

Quick answer

Delgocitinib cream, Cream Vehicle for Mild to severe palmoplantar pustulosis is a Phase 2 program (small_molecule) at LEO Pharma A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
LEO Pharma A/S
Indication
Mild to severe palmoplantar pustulosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials